Literature DB >> 29923037

Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6-/- Neurons and Astrocytes Treated with Lipopolysaccharides.

Juan Ma1, Fa-Li Zhang1, Gan Zhou2, Yu-Xin Bao3, Yuan Shen1, Zhong-Ming Qian4,5.   

Abstract

A region-specific regulation of inflammation on the expression hepcidin in the brain has been demonstrated, however, it remains unknown whether there is also a cell-specific regulation of inflammation on hepcidin in the brain. Here, we investigated the effects of lipopolysaccharides (LPS) on the expression of hepcidin mRNA and also the expression of IL-6 mRNA, the phosphorylation of STAT3 and the expression of ferroportin 1 (Fpn1) and ferritin light chain (Ft-L) proteins in neurons and astrocytes obtained from wild type (IL-6+/+) and IL-6 knockout (IL-6-/-) mice. We demonstrated that the responses of the expression of hepcidin and IL-6 mRNAs, the phosphorylation of STAT3, and the expression of Fpn1 protein to LPS in IL-6+/+ astrocytes and also the responses of the expression of hepcidin mRNA, the phosphorylation of STAT3 and the expression of Fpn1 protein to IL-6 in IL-6-/- astrocytes were much stronger than those in IL-6+/+ and IL-6-/- neurons. A significant increase in Ft-L was found in LPS-treated IL-6+/+ and IL-6-treated IL-6-/- astrocytes, but not in LPS-treated IL-6+/+ and IL-6-treated IL-6-/- neurons. Our findings provide in vitro evidence for the existence of a cell-specific regulation of LPS on the expression of hepcidin and also Ft-L in the brain.

Entities:  

Keywords:  Ferritin light chain (Ft-L) and cell iron content; Hepcidin and ferroportin 1 (Fpn1); IL-6/STAT3 pathway; Lipopolysaccharides (LPS); Neuron and astrocyte

Mesh:

Substances:

Year:  2018        PMID: 29923037     DOI: 10.1007/s11064-018-2577-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase.

Authors:  Shen-Ting Zhao; Xiao-Tian Huang; Ce Zhang; Ya Ke
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.

Authors:  Xiao-Tian Huang; Zhong-Ming Qian; Xuan He; Qi Gong; Ka-Chun Wu; Li-Rong Jiang; Li-Na Lu; Zhou-Jing Zhu; Hai-Yan Zhang; Wing-Ho Yung; Ya Ke
Journal:  Neurobiol Aging       Date:  2013-11-13       Impact factor: 4.673

4.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

5.  Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures.

Authors:  Fang Du; Zhong Ming Qian; Li Zhu; Xiao Mei Wu; Christopher Qian; Robbie Chan; Ya Ke
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

6.  Role of soluble ceruloplasmin in iron uptake by midbrain and hippocampus neurons.

Authors:  Ya Ke; Kwokping Ho; Jinrong Du; Li Zhu; Youjia Xu; Qin Wang; Chen Yuen Wang; Lianzhi Li; Xiaohu Ge; Yangzhong Chang; Zhong Ming Qian
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

7.  Expression and cellular localization of hepcidin mRNA and protein in normal rat brain.

Authors:  Ruma Raha-Chowdhury; Animesh Alexander Raha; Serhiy Forostyak; Jing-Wei Zhao; Simon Russell William Stott; Adrian Bomford
Journal:  BMC Neurosci       Date:  2015-04-21       Impact factor: 3.288

8.  Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide.

Authors:  Wan-Ying Li; Fei-Mi Li; Yu-Fu Zhou; Zhong-Min Wen; Juan Ma; Ke Ya; Zhong-Ming Qian
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

9.  Expression of iron-related genes in human brain and brain tumors.

Authors:  Milla M Hänninen; Joonas Haapasalo; Hannu Haapasalo; Robert E Fleming; Robert S Britton; Bruce R Bacon; Seppo Parkkila
Journal:  BMC Neurosci       Date:  2009-04-22       Impact factor: 3.288

Review 10.  Hepcidin antagonists for potential treatments of disorders with hepcidin excess.

Authors:  Maura Poli; Michela Asperti; Paola Ruzzenenti; Maria Regoni; Paolo Arosio
Journal:  Front Pharmacol       Date:  2014-04-28       Impact factor: 5.810

View more
  4 in total

Review 1.  Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis.

Authors:  Núria DeGregorio-Rocasolano; Octavi Martí-Sistac; Teresa Gasull
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

2.  Hepcidin overexpression in astrocytes alters brain iron metabolism and protects against amyloid-β induced brain damage in mice.

Authors:  Xinwei Zhang; Yu-Jing Gou; Yating Zhang; Jie Li; Kang Han; Yong Xu; Haiyan Li; Lin-Hao You; Peng Yu; Yan-Zhong Chang; Guofen Gao
Journal:  Cell Death Discov       Date:  2020-10-30

Review 3.  Inflaming the Brain with Iron.

Authors:  Pamela J Urrutia; Daniel A Bórquez; Marco Tulio Núñez
Journal:  Antioxidants (Basel)       Date:  2021-01-06

Review 4.  The Dual Role of Hepcidin in Brain Iron Load and Inflammation.

Authors:  Driton Vela
Journal:  Front Neurosci       Date:  2018-10-15       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.